Dual purpose: some cancer therapies used to treat autoimmune diseases

J Natl Cancer Inst. 2004 Apr 21;96(8):577-9. doi: 10.1093/jnci/96.8.577.
No abstract available

Publication types

  • Historical Article
  • News

MeSH terms

  • Antibodies, Monoclonal / pharmacology
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • Autoimmune Diseases / drug therapy*
  • Clinical Trials as Topic
  • Cyclophosphamide / pharmacology
  • Daclizumab
  • Europe
  • History, 20th Century
  • Humans
  • Immunoglobulin G / pharmacology
  • Immunosuppressive Agents / pharmacology*
  • Immunosuppressive Agents / therapeutic use
  • Mechlorethamine / pharmacology
  • Methotrexate / pharmacology
  • Neoplasms / drug therapy*
  • Rituximab
  • Warfare

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Rituximab
  • Mechlorethamine
  • Cyclophosphamide
  • Daclizumab
  • Methotrexate